Qunxing Li,md

This phase 3 trial tests whether adding the immunotherapy drug sintilimab to chemotherapy before and after surgery can improve outcomes for people with advanced oral cancer. About 104 participants will be randomly assigned to receive either the combination therapy or standard sur…

This study is testing whether people with advanced head and neck cancer who respond well to immunotherapy can have a smaller, less invasive surgery instead of the standard extensive surgery. The goal is to see if the smaller surgery works just as well at controlling the cancer wh…